You searched for Gout - Page 57 of 96

Abstract Number: 2586 • 2012 ACR/ARHP Annual Meeting
Tendon and Ligament Involvement in Gout: A Dual Energy Computed Tomography Study
Nicola Dalbeth¹, Ramanamma Kalluru², Opetaia Aati³, Fiona M. McQueen⁴ and Anthony Doyle⁵, ¹Medicine, University of Auckland, Auckland, New Zealand, ²Department of Rheumatology, Auckland District Health Board, Auckland, New Zealand, ³Department of Medicine, University of Auckland, Auckland, New Zealand, ⁴Molecular Medicine and Pathology, University of Auckland, Auckland, New Zealand, ⁵University of Auckland, Auckland, New Zealand
Background/Purpose: The involvement of bone and joints is widely recognized in gout. However, soft tissue involvement is less well defined. Dual energy computed tomography (DECT)…
Abstract Number: 2585 • 2012 ACR/ARHP Annual Meeting
Magnetic Resonance Imaging Versus Dual Energy Computed Tomography for Detection of Joint Pathology in Gout
Fiona M. McQueen¹, Anthony Doyle², Quentin Reeves³, Angela Gao³, Amy Tsai³, Gregory Gamble⁴, Barbara Curteis¹, Megan Williams⁵ and Nicola Dalbeth⁶, ¹Molecular Medicine and Pathology, University of Auckland, Auckland, New Zealand, ²University of Auckland, Auckland, New Zealand, ³Radiology, Auckland District Health Board, Auckland, New Zealand, ⁴Department of Medicine, University of Auckland, Auckland, New Zealand, ⁵Rheumatology, Auckland District Health Board, Auckland, New Zealand, ⁶Medicine, University of Auckland, Auckland, New Zealand
Background/Purpose: Magnetic resonance imaging (MRI) captures joint inflammation and damage in gouty arthropathy and can also reveal tophi. We have investigated reader reliability for scoring…
Abstract Number: 2461 • 2012 ACR/ARHP Annual Meeting
Cost-Effectiveness of Systemic Therapies for Acute Gouty Arthritis
Kimberly Reiter¹, Jeremy Goldhaber-Fiebert² and Eswar Krishnan³, ¹Division of Rheumatology, Stanford University School of Medicine, Palo Alto, CA, ²Center for Health Policy/Center for Primary Care and Outcomes Research, Stanford, Stanford, CA, ³Medicine, Standford University, Palo Alto, CA
Background/Purpose: Rising prevalence has led to increased demand for newer and potentially costly treatments for acute gouty arthritis, but few studies comparing effectiveness and costs…
Abstract Number: 2412 • 2012 ACR/ARHP Annual Meeting
Valdiation of a Diagnosis of Gout in the Epiccare Electronic Medical Records
Neera Narang¹ and Eswar Krishnan², ¹Stanford Univ Medical Center, Stanford, CA, ²Medicine, Standford University, Palo Alto, CA
Background/Purpose: Electronic Medical Records (EMR) offer great opportunities for pharmacoepidemiologic, health outcome and health services research. However, the critical limiting factor in the widespread use of…
Abstract Number: 2041 • 2012 ACR/ARHP Annual Meeting
Improving Access and Patient Education in Rheumatology: the Gout Shared Medical Appointment; a Quality Improvement Initiative
Alicia J. Zbehlik¹ and Nicole M. Orzechowski², ¹Rheumatology, Dartmouth-Hitchcock Medical Center, Lebanon, NH, ²Section of Rheumatology, Dartmouth-Hitchcock Med Ctr, Lebanon, NH
Background/Purpose: Patients experience long waits for consultations in Rheumatology at Dartmouth-Hitchcock Medical Center (DHMC). The cause of this is multi-factorial, including provider referral patterns, patient preferences,…
Abstract Number: 2043 • 2012 ACR/ARHP Annual Meeting
Documentation of Improvement Over 2 Months in Osteoarthritis, Systemic Lupus Erythematosus, Spondyloarthropathy and Gout Similarly to Rheumatoid Arthritis According to Function, Pain, Patient Global Estimate and RAPID3 On a Multidimensional Health Assessment Questionnaire (MDHAQ)
Isabel Castrejón¹, Martin J. Bergman² and Theodore Pincus¹, ¹Rheumatology, Rush University Medical Center, Chicago, IL, ²Taylor Hospital, Ridley Park, PA
Background/Purpose: The health assessment questionnaire (HAQ) and multidimensional HAQ (MDHAQ) were developed initially to assess patients with rheumatoid arthritis (RA). The most feasible method to…
Abstract Number: 2045 • 2012 ACR/ARHP Annual Meeting
Treatment Patterns and Monitoring of Serum Uric Acid Levels in a Large Cohort of Gout Patients in the United States: Is There Room for Improvement?
Yong Chen¹, Kasem S. Akhras², Michael Grabner¹, Rima H. Tawk³ and Ralph Quimbo¹, ¹HealthCore, Inc., Wilmington, DE, ²Global Outcomes Research, Takeda Pharmaceuticals International, Inc., Deerfield, IL, ³Center for pharmacoeconomic Research, University of Illinois at Chicago, Chicago, IL
Background/Purpose: Currently, there are no guidelines in the United States on monitoring serum uric acid (sUA) levels in gout and gout treatment patterns. However, there…
Abstract Number: 2037 • 2012 ACR/ARHP Annual Meeting
Poor Quality of Gout Care Is Strongly Associated with Higher Gout-Related Health Care Utilization
Jasvinder A. Singh¹ and Joshua Richman², ¹Department of Medicine, University of Alabama, Tuscaloosa, AL, ²Biostatistics, UAB School of Medicine, Birmingham, AL
Background/Purpose: Proponents of improving quality of gout care have suggested various gout quality indicators, but no study to date has shown the link between…
Abstract Number: 1901 • 2012 ACR/ARHP Annual Meeting
Chronic Gout. Improvement According to Outcome Meaures in Rheumatology Domains in Daily Clinical Practice
Janitzia Vazquez-Mellado¹, Betsabé Serrano¹, Jaime Mendoza², Sergio Garcia-Mendez¹, V.Chantal Hernández¹, Virginia Pascual Ramos³, Ruben Burgos-Vargas¹ and Marina Rull-Gabayet², ¹Rheumatology, Hospital General de Mexico, Mexico city, Mexico, ²Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico, ³Dept de Immunología y Reumato, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico
Background/Purpose: OMERACT has proposed domains to evaluate the effect of treatment in patients with acute and chronic gout. Their frequency, time to improve and percentage…
Abstract Number: 1902 • 2012 ACR/ARHP Annual Meeting
What Factors Are Associated with Target Serum Urate Concentrations in Patients with Gout?
Nicola Dalbeth¹, Meaghan House², Anne Horne², Keith J. Petrie³, Fiona M. McQueen⁴ and William Taylor⁵, ¹Medicine, University of Auckland, Auckland, New Zealand, ²Department of Medicine, University of Auckland, Auckland, New Zealand, ³University of Auckland, Auckland, New Zealand, ⁴Molecular Medicine and Pathology, University of Auckland, Auckland, New Zealand, ⁵University of Otago, Wellington, New Zealand
Background/Purpose: Long term serum urate (SU) lowering to a target of
Abstract Number: 1903 • 2012 ACR/ARHP Annual Meeting
Oxidation of Urate to Allantoin by Myeloperoxidase in Gout
Lisa K. Stamp¹, Irada Khalilova², Mei Zhang¹, Rufus Turner² and Anthony Kettle², ¹Department of Medicine, University of Otago, Christchurch, Christchurch, New Zealand, ²Pathology, University of Otago, Christchurch, Christchurch, New Zealand
Background/Purpose : Hyperuricaemia is critical for the development of gout and may play a pivotal role in the pathophysiology of hypertension, metabolic syndrome, and cardiovascular…
Abstract Number: 1904 • 2012 ACR/ARHP Annual Meeting
Patterns of Gout Treatment and Related Outcomes in US Community Rheumatology Practices: the Relation Between Gout Flares, Time in Treatment, Serum Uric Acid Level and Urate Lowering Therapy
Max I. Hamburger¹, John RP Tesser², John L. Skosey³, Allan H. Morton⁴ and Karl M. Kilgore⁵, ¹Rheumatology Associates, Melville, NY, ²AZ Arthritis Rheum Assoc, Paradise Valley, AZ, ³Illinois Bone & Joint Institut, Chicago, IL, ⁴Warren, MI, ⁵Cetus Group, LLC, Hunt Valley, MD
Background/Purpose: Study patterns of gout treatment and related outcomes in US community rheumatology practices, specifically the relation between likelihood and severity of gout flares, time…
Abstract Number: 1906 • 2012 ACR/ARHP Annual Meeting
Changes in Gout patient´s Clinical Profile in the Last Two Decades
Fernando Perez-Ruiz¹ and Ana M. Herrero-Beites², ¹Servicio de Reumatologia, Hospital Universitario Cruces, Baracaldo, Spain, ²Physical Medicine Division, Hospital de Gorliz, Gorliz, Spain
Background/Purpose: to assess whether changes in the clinical profile of gout are observed in a large cohort of gout patients over the last 20 years.…
Abstract Number: 1907 • 2012 ACR/ARHP Annual Meeting
Pharmacological Management of Gout in Italy in the Years 2005-2009: A Nationwide, Population-Based Study
Lorenzo Cavagna¹, Gianluca Trifirò², Roberto Caporali³, P. Morabito², C. Ferrajolo⁴, S. Pecchioli⁵, M. Simonetti⁵, G. Medea⁶, C. Cricelli⁷, A. Caputi², G. Mazzaglia⁵ and Carlomaurizio Montecucco⁸, ¹Rheumatology, University and IRCCS Policlinico S. Matteo Foundation, Pavia, Italy, ²Department of Clinical and Experimental Medicine and Pharmacology, University of Messina, Italy, ³Division of Rheumatology, IRCCSPoliclinico S. Matteo Foundation, Pavia, Italy, ⁴Department of Experimental Medicine, Pharmacology Section, Second University of Naples, Naples, Italy, ⁵Health Search, Italian College of General Practitioners, Italy, ⁶Italian college of General Practitioner, Italy, ⁷Italian college of General Practitioner, Pavia (italy), Italy, ⁸Division of Rheumatology, University of Pavia School of Medicine, IRCCS Policlinico San Matteo Foundation, Pavia, Italy
Background/Purpose: Despite the increasing interest on gout, only few nationwide drug utilization studies have been conducted on this topic. The aim of this study…
Abstract Number: 1908 • 2012 ACR/ARHP Annual Meeting
Multinational Evidence-Based Recommendations for Diagnosis and Management of Gout: Integrating Systematic Literature Research and Expert Opinion of a Broad Panel of Rheumatologists in the 3E Initiative
Mariano Andres¹, Francisca Sivera², Alison Kydd³, John Moi⁴, Rakhi Seth⁵, Melonie K. Sriranganathan⁶, Caroline van Durme⁷, Irene AAM van Echteld⁸, Ophir Vinik⁹, Mihir D. Wechalekar¹⁰, Daniel Aletaha¹¹, Claire Bombardier⁹, Rachelle Buchbinder¹², Loreto Carmona¹³, Christopher J. Edwards¹⁴, R. Landewe¹⁵ and Désirée van der Heijde¹⁶, ¹Seccion Reumatologia, Hospital General Universitario de Alicante, Alicante, Spain, ²Sección de Reumatología, Hospital General Universitario de Elda, Alicante, Spain, ³Division of Rheumatology, University of British Columbia, Vancouver, BC, Canada, ⁴Royal Melbourne Hospital, Melbourne, Australia, ⁵Rheumatology, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom, ⁶Rheumatology, St. Mary's Hospital, Isle of Wight, United Kingdom, ⁷Maastricht University Medical Centre, Maastricht, Netherlands, ⁸Atrium Medical Center, Heerlen, Netherlands, ⁹Rheumatology, University of Toronto, Toronto, ON, Canada, ¹⁰Flinders University School of Medicine, Adelaide, Australia, ¹¹Department of Internal Medicine III, Division of Rheumatology, Medical University of Vienna, Vienna, Austria, ¹²Monash Department of Clinical Epidemiology at Cabrini Hospital, Department of Epidemiology and Preventive Medicine, Monash University, Malvern, Victoria, Australia, ¹³Health Sciences School, Universidad Camilo José Cela, Villanueva de la Cañada, Spain, ¹⁴NIHR Wellcome Trust Clinical Research Facility, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom, ¹⁵Division of Clinical Immunology and Rheumatology, Academic Medical Center / University of Amsterdam, Amsterdam, Netherlands, ¹⁶Rheumatology, Leiden University Medical Center, Leiden, Netherlands
Background/Purpose: The 3e (Evidence, Expertise, Exchange) Initiative is a multinational collaboration that aims to promote evidence-based medicine in rheumatology. The 2011-12 3e Initiative aimed to…

Tendon and Ligament Involvement in Gout: A Dual Energy Computed Tomography Study

Magnetic Resonance Imaging Versus Dual Energy Computed Tomography for Detection of Joint Pathology in Gout

Cost-Effectiveness of Systemic Therapies for Acute Gouty Arthritis

Valdiation of a Diagnosis of Gout in the Epiccare Electronic Medical Records

Improving Access and Patient Education in Rheumatology: the Gout Shared Medical Appointment; a Quality Improvement Initiative

Documentation of Improvement Over 2 Months in Osteoarthritis, Systemic Lupus Erythematosus, Spondyloarthropathy and Gout Similarly to Rheumatoid Arthritis According to Function, Pain, Patient Global Estimate and RAPID3 On a Multidimensional Health Assessment Questionnaire (MDHAQ)

Treatment Patterns and Monitoring of Serum Uric Acid Levels in a Large Cohort of Gout Patients in the United States: Is There Room for Improvement?

Poor Quality of Gout Care Is Strongly Associated with Higher Gout-Related Health Care Utilization

Chronic Gout. Improvement According to Outcome Meaures in Rheumatology Domains in Daily Clinical Practice

What Factors Are Associated with Target Serum Urate Concentrations in Patients with Gout?

Oxidation of Urate to Allantoin by Myeloperoxidase in Gout

Patterns of Gout Treatment and Related Outcomes in US Community Rheumatology Practices: the Relation Between Gout Flares, Time in Treatment, Serum Uric Acid Level and Urate Lowering Therapy

Changes in Gout patient´s Clinical Profile in the Last Two Decades

Pharmacological Management of Gout in Italy in the Years 2005-2009: A Nationwide, Population-Based Study

Multinational Evidence-Based Recommendations for Diagnosis and Management of Gout: Integrating Systematic Literature Research and Expert Opinion of a Broad Panel of Rheumatologists in the 3E Initiative

Simple Search Results